Index
Module 13 • GI/Endocrine
Hepatic Failure, GI & Endocrine Emergencies
92%
Core Content
Hepatic Failure, GI & Endocrine Emergencies
Stephanie N. Bass ~3 min read Module 13 of 20
60
/ 65

Hepatic Failure/GI/Endocrine Emergencies

bleeds.Β Ann Pharmacother. 2019;53(8):794-800. https://

doi.org/10.1177/1060028019833696

Sachar H, Vaidya K, Laine L. Intermittent vs con-

tinuous proton pump inhibitor therapy for high-risk

bleeding ulcers: a systematic review and meta-analy-

sis.Β  JAMA Intern Med. 2014;174(11):1755-1762. https://

doi.org/10.1001/jamainternmed.2014.4056

Saltzman JR, Tabak YP, Hyett BH, Sun X, Travis AC,

Johannes RS. A simple risk score accurately predicts in-

hospital mortality, length of stay, and cost in acute upper

GI bleeding.Β Gastrointest Endosc. 2011;74(6):1215-1224.

https://doi.org/10.1016/j.gie.2011.06.024

Srygley FD, Gerardo CJ, Tran T, Fisher DA. Does

this patient have a severe upper gastrointestinal

bleed?.Β  JAMA. 2012;307(10):1072-1079. https://doi.

org/10.1001/jama.2012.253

Sung JJ, Lau JY, Ching JY, et al. Continuation of

low-dose aspirin therapy in peptic ulcer bleeding: a ran-

domized trial.Β Ann Intern Med. 2010;152(1):1-9. https://

doi.org/10.7326/0003-4819-152-1-201001050-00179

Villanueva C, Colomo A, Bosch A, et al. Transfusion

strategies for acute upper gastrointestinal bleeding. N

Engl J Med. 2013;368(1):11-21. https://doi.org/10.1056/

nejmoa1211801

Witt DM, Delate T, Garcia DA, et al. Risk of thromboem-

bolism, recurrent hemorrhage, and death after warfarin

therapy interruption for gastrointestinal tract bleed-

ing.Β  Arch Intern Med. 2012;172(19):1484-1491.Β  https://

doi.org/10.1001/archinternmed.2012.4261

Wuerth BA, Rockey DC. Changing epidemiology of

upper gastrointestinal hemorrhage in the last decade: a

nationwide analysis.Β Dig Dis Sci. 2018;63(5):1286-1293.

https://doi.org/10.1007/s10620-017-4882-6

Endocrine Emergencies

American Diabetes Association. 13. Diabetes care in

the hospital, nursing home, and skilled nursing facil-

ity.Β Diabetes Care. 2015;38 Suppl:S80-S85. https://doi.

org/10.2337/dc15-s016

Annane D, Pastores SM, Rochwerg B, et al. Guidelines

for the diagnosis and management of critical illness-

related corticosteroid insufficiency (CIRCI) in critically

ill patients (part I): Society of Critical Care Medicine
(SCCM) and European Society of Intensive Care Medicine
(ESICM) 2017.Β Crit Care Med. 2017;45(12):2078-2088.

https://doi.org/10.1097/ccm.0000000000002737

Bornstein SR. Predisposing factors for adrenal insuffi-

ciency.Β N Engl J Med. 2009;360(22):2328-2339. https://

doi.org/10.1056/nejmra0804635

Brunkhorst FM, Engel C, Bloos F, et al. Intensive

insulin therapy and pentastarch resuscitation in severe

sepsis.Β N Engl J Med. 2008;358(2):125-139. https://doi.

org/10.1056/nejmoa070716

Burch HB, Cooper DS. Management of Graves disease:

a review.Β  JAMA. 2015;314(23):2544-2554. https://doi.

org/10.1001/jama.2015.16535

Cooper DS. Antithyroid drugs.Β  N Engl J Med.

2005;352(9):905-917.

https://doi.org/10.1056/

nejmra042972

Cooper MS, Stewart PM. Corticosteroid insufficiency in

acutely ill patients.Β N Engl J Med. 2003;348(8):727-734.

https://doi.org/10.1056/nejmra020529

Cryer

PE.

Mechanisms

of

hypoglycemia-asso-

ciated autonomic failure in diabetes.Β  N Engl J

Med.

2013;369(4):362-372.

https://doi.org/10.1056/

nejmra1215228

Cryer PE, Axelrod L, Grossman AB, et al. Evaluation

and management of adult hypoglycemic disorders: an

Endocrine Society Clinical Practice Guideline.Β J Clin

Endocrinol Metab. 2009;94(3):709-728. https://doi.

org/10.1210/jc.2008-1410

Devereaux D, Tewelde SZ. Hyperthyroidism and thyro-

toxicosis.Β Emerg Med Clin North Am. 2014;32(2):277-292.

https://doi.org/10.1016/j.emc.2013.12.001

Dubbs SB, Spangler R. Hypothyroidism: causes, kill-

ers, and life-saving treatments.Β  Emerg Med Clin

North Am. 2014;32(2):303-317.Β  https://doi.org/10.1016/j.

emc.2013.12.003

ElSayed NA, Aleppo G, Aroda VR, et al. 16. Diabetes

care in the hospital: standards of care in diabe-

tesβ€”2023.Β Diabetes Care. 2023;46(Suppl 1):S267-S278.

https://doi.org/10.2337/dc23-s016

Honarmand K, Sirimaturos M, Hirshberg EL, et al.

Society of Critical Care Medicine guidelines on gly-

cemic control for critically ill children and adults

2024.Β Crit Care Med. 2024;52(4):e161-e181. https://doi.

org/10.1097/ccm.0000000000006174

Jaber S, Paugam C, Futier E, et al. Sodium bicarbon-

ate therapy for patients with severe metabolic acidaemia

in the intensive care unit (BICAR-ICU): a multicen-

tre, open-label, randomised controlled, phase 3 trial.

Ψ΄Ψ±Ψ­ Ψ§Ω„ΩΩŠΨ―ΩŠΩˆ Ψ§Ω„ΨͺΨΉΩ„ΩŠΩ…ΩŠ β€” Ω…Ψ²Ψ§Ω…Ω†Ψ© Ω…ΨΉ Ψ§Ω„Ω€ PDF
Ψ¨Ψ―Ψ‘ Ψ§Ω„ΨͺΨ΄ΨΊΩŠΩ„ Ω…Ω†: Ψ§Ω„Ψ―Ω‚ΩŠΩ‚Ψ© 59 فΨͺΨ­ ΨΉΩ„Ω‰ YouTube